A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation
Trial details
- Registry ID
- NCT06005974
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC MutationNCT06005974 | RXRX | Phase 2 | Terminated | 2025-02-24Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |